{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:47:58Z","timestamp":1785941278710,"version":"3.56.0"},"reference-count":215,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Protoc"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41596-025-01306-w","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:43:21Z","timestamp":1770137001000},"page":"3371-3411","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Conjugation of hydrophobic drugs to motile pRNA 4WJ nanoparticles for spontaneous tumor targeting and undetectable toxicity"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9325-7942","authenticated-orcid":false,"given":"Daniel W.","family":"Binzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tesla","family":"Yudhistira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5706-2833","authenticated-orcid":false,"given":"Peixuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"1306_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0378-5173(01)00986-3","volume":"235","author":"AK Singla","year":"2002","unstructured":"Singla, A. K., Garg, A. & Aggarwal, D. Paclitaxel and its formulations. Int. J. Pharm. 235, 179\u2013192 (2002).","journal-title":"Int. J. Pharm."},{"key":"1306_CR2","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.biomaterials.2006.11.013","volume":"28","author":"SQ Liu","year":"2007","unstructured":"Liu, S. Q., Wiradharma, N., Gao, S. J., Tong, Y. W. & Yang, Y. Y. Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs. Biomaterials 28, 1423\u20131433 (2007).","journal-title":"Biomaterials"},{"key":"1306_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/IJN.S596","volume":"3","author":"WH De Jong","year":"2008","unstructured":"De Jong, W. H. & Borm, P. J. Drug delivery and nanoparticles: applications and hazards. Int. J. Nanomed. 3, 133\u2013149 (2008).","journal-title":"Int. J. Nanomed."},{"key":"1306_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/bs.apcsb.2014.11.002","volume":"98","author":"H Kouchakzadeh","year":"2015","unstructured":"Kouchakzadeh, H., Safavi, M. S. & Shojaosadati, S. A. Efficient delivery of therapeutic agents by using targeted albumin nanoparticles. Adv. Protein Chem. Struct. Biol. 98, 121\u2013143 (2015).","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"1306_CR5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/wnan.6","volume":"1","author":"SE McNeil","year":"2009","unstructured":"McNeil, S. E. Nanoparticle therapeutics: a personal perspective. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1, 264\u2013271 (2009).","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"1306_CR6","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1208\/s12248-012-9339-4","volume":"14","author":"N Desai","year":"2012","unstructured":"Desai, N. Challenges in development of nanoparticle-based therapeutics. AAPS J. 14, 282\u2013295 (2012).","journal-title":"AAPS J."},{"key":"1306_CR7","doi-asserted-by":"publisher","first-page":"4764","DOI":"10.3390\/molecules25204764","volume":"25","author":"U Hafeez","year":"2020","unstructured":"Hafeez, U., Parakh, S., Gan, H. K. & Scott, A. M. Antibody-drug conjugates for cancer therapy. Molecules 25, 4764 (2020).","journal-title":"Molecules"},{"key":"1306_CR8","first-page":"165","volume":"72","author":"P Tarantino","year":"2022","unstructured":"Tarantino, P. et al. Antibody-drug conjugates: smart chemotherapy delivery across tumor histologies. CA Cancer J. Clin. 72, 165\u2013182 (2022).","journal-title":"CA Cancer J. Clin."},{"key":"1306_CR9","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2021.1951427","volume":"13","author":"AQ Dean","year":"2021","unstructured":"Dean, A. Q., Luo, S., Twomey, J. D. & Zhang, B. Targeting cancer with antibody-drug conjugates: promises and challenges. MAbs 13, 1951427 (2021).","journal-title":"MAbs"},{"key":"1306_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s12272-023-01447-0","volume":"46","author":"R Maiti","year":"2023","unstructured":"Maiti, R. et al. Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities. Arch. Pharm. Res. 46, 361\u2013388 (2023).","journal-title":"Arch. Pharm. Res."},{"key":"1306_CR11","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1126\/science.3107124","volume":"236","author":"PX Guo","year":"1987","unstructured":"Guo, P. X., Erickson, S. & Anderson, D. A small viral RNA is required for in vitro packaging of bacteriophage \u03d529 DNA. Science 236, 690\u2013694 (1987).","journal-title":"Science"},{"key":"1306_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S1097-2765(00)80124-0","volume":"2","author":"P Guo","year":"1998","unstructured":"Guo, P., Zhang, C., Chen, C., Garver, K. & Trottier, M. Inter-RNA interaction of phage \u03d529 pRNA to form a hexameric complex for viral DNA transportation. Mol. Cell 2, 149\u2013155 (1998).","journal-title":"Mol. Cell"},{"key":"1306_CR13","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nnano.2010.231","volume":"5","author":"P Guo","year":"2010","unstructured":"Guo, P. The emerging field of RNA nanotechnology. Nat. Nanotechnol. 5, 833\u2013842 (2010).","journal-title":"Nat. Nanotechnol."},{"key":"1306_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.addr.2013.11.006","volume":"66","author":"Y Shu","year":"2014","unstructured":"Shu, Y. et al. Stable RNA nanoparticles as potential new generation drugs for cancer therapy. Adv. Drug Deliv. Rev. 66, 74\u201389 (2014).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"1306_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi, N., Hogan, M. J., Porter, F. W. & Weissman, D. mRNA vaccines\u2014a new era in vaccinology. Nat. Rev. Drug Discov. 17, 261\u2013279 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1306_CR16","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","volume":"586","author":"KS Corbett","year":"2020","unstructured":"Corbett, K. S. et al. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature 586, 567\u2013571 (2020).","journal-title":"Nature"},{"key":"1306_CR17","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","volume":"383","author":"LA Jackson","year":"2020","unstructured":"Jackson, L. A. et al. An mRNA vaccine against SARS-CoV-2\u2014preliminary report. N. Engl. J. Med. 383, 1920\u20131931 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1306_CR18","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s40265-018-0983-6","volume":"78","author":"SM Hoy","year":"2018","unstructured":"Hoy, S. M. Patisiran: first global approval. Drugs 78, 1625\u20131631 (2018).","journal-title":"Drugs"},{"key":"1306_CR19","doi-asserted-by":"publisher","first-page":"7398","DOI":"10.1021\/acs.chemrev.1c00009","volume":"121","author":"DW Binzel","year":"2021","unstructured":"Binzel, D. W. et al. Thermostability, tunability, and tenacity of RNA as rubbery anionic polymeric materials in nanotechnology and nanomedicine-specific cancer targeting with undetectable toxicity. Chem. Rev. 121, 7398\u20137467 (2021).","journal-title":"Chem. Rev."},{"key":"1306_CR20","doi-asserted-by":"publisher","first-page":"13180","DOI":"10.1021\/acsnano.0c04863","volume":"14","author":"C Ghimire","year":"2020","unstructured":"Ghimire, C. et al. RNA nanoparticles as rubber for compelling vessel extravasation to enhance tumor targeting and for fast renal excretion to reduce toxicity. ACS Nano 14, 13180\u201313191 (2020).","journal-title":"ACS Nano"},{"key":"1306_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114316","volume":"186","author":"X Li","year":"2022","unstructured":"Li, X., Bhullar, A. S., Binzel, D. W. & Guo, P. The dynamic, motile and deformative properties of RNA nanoparticles facilitate the third milestone of drug development. Adv. Drug Deliv. Rev. 186, 114316 (2022).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"1306_CR22","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1166\/jnn.2005.446","volume":"5","author":"P Guo","year":"2005","unstructured":"Guo, P. RNA nanotechnology: engineering, assembly and applications in detection, gene delivery and therapy. J. Nanosci. Nanotechnol. 5, 1964\u20131982 (2005).","journal-title":"J. Nanosci. Nanotechnol."},{"key":"1306_CR23","doi-asserted-by":"publisher","first-page":"4206","DOI":"10.2174\/092986711797189600","volume":"18","author":"X Ni","year":"2011","unstructured":"Ni, X., Castanares, M., Mukherjee, A. & Lupold, S. E. Nucleic acid aptamers: clinical applications and promising new horizons. Curr. Med. Chem. 18, 4206\u20134214 (2011).","journal-title":"Curr. Med. Chem."},{"key":"1306_CR24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/prca.201200042","volume":"6","author":"V Thiviyanathan","year":"2012","unstructured":"Thiviyanathan, V. & Gorenstein, D. G. Aptamers and the next generation of diagnostic reagents. Proteom. Clin. Appl. 6, 563\u2013573 (2012).","journal-title":"Proteom. Clin. Appl."},{"key":"1306_CR25","first-page":"153","volume":"131","author":"KN Kang","year":"2013","unstructured":"Kang, K. N. & Lee, Y. S. RNA aptamers: a review of recent trends and applications. Adv. Biochem. Eng. Biotechnol. 131, 153\u2013169 (2013).","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"key":"1306_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.59566\/ISRNN.2024.0101109","volume":"1","author":"C Xu","year":"2024","unstructured":"Xu, C. et al. Conversion of chemical drugs into targeting ligands on RNA nanoparticles and assessing payload stoichiometry for optimal biodistribution in cancer treatment. RNA Nanomed. 1, 109\u2013123 (2024).","journal-title":"RNA Nanomed."},{"key":"1306_CR27","volume":"2","author":"DW Binzel","year":"2025","unstructured":"Binzel, D. W. et al. RNA nanoparticles harboring radioisotopes or other imaging molecules for spontaneous tumor targeting for early cancer diagnosis. RNA Nanomed. 2, 10.59566\/isrnn.2025.0201d (2025).","journal-title":"RNA Nanomed."},{"key":"1306_CR28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ymeth.2011.01.008","volume":"54","author":"Y Shu","year":"2011","unstructured":"Shu, Y., Cinier, M., Shu, D. & Guo, P. Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells. Methods 54, 204\u2013214 (2011).","journal-title":"Methods"},{"key":"1306_CR29","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/mt.2016.85","volume":"24","author":"D Binzel","year":"2016","unstructured":"Binzel, D. et al. Specific delivery of miRNA for high efficient inhibition of prostate cancer by RNA nanotechnology. Mol. Ther. 24, 1267\u20131277 (2016).","journal-title":"Mol. Ther."},{"key":"1306_CR30","doi-asserted-by":"publisher","first-page":"101085","DOI":"10.1016\/j.redox.2018.101085","volume":"21","author":"Y Xu","year":"2019","unstructured":"Xu, Y. et al. Specific delivery of delta-5-desaturase siRNA via RNA nanoparticles supplemented with dihomo-\u03b3-linolenic acid for colon cancer suppression. Redox Biol. 21, 101085\u2013101093 (2019).","journal-title":"Redox Biol."},{"key":"1306_CR31","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.omtn.2023.07.027","volume":"33","author":"L Yang","year":"2023","unstructured":"Yang, L., Li, Z., Binzel, D. W., Guo, P. & Williams, T. M. Targeting oncogenic KRAS in non-small cell lung cancer with EGFR aptamer-conjugated multifunctional RNA nanoparticles. Mol. Ther. Nucleic Acids 33, 559\u2013571 (2023).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1306_CR32","doi-asserted-by":"publisher","first-page":"9731","DOI":"10.1021\/acsnano.5b02471","volume":"9","author":"D Shu","year":"2015","unstructured":"Shu, D. et al. Systemic delivery of anti-miRNA for suppression of triple negative breast cancer utilizing RNA nanotechnology. ACS Nano 9, 9731\u20139740 (2015).","journal-title":"ACS Nano"},{"key":"1306_CR33","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.ymthe.2019.04.018","volume":"27","author":"H Yin","year":"2019","unstructured":"Yin, H. et al. Delivery of anti-miRNA for triple-negative breast cancer therapy using RNA nanoparticles targeting stem cell marker CD133. Mol. Ther. 27, 1252\u20131261 (2019).","journal-title":"Mol. Ther."},{"key":"1306_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jconrel.2020.12.007","volume":"330","author":"H Wang","year":"2020","unstructured":"Wang, H. et al. Multivalent rubber-like RNA nanoparticles for targeted co-delivery of paclitaxel and MiRNA to silence the drug efflux transporter and liver cancer drug resistance. J. Control. Release 330, 173\u2013184 (2020).","journal-title":"J. Control. Release"},{"key":"1306_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.59566\/ISRNN.2025.0201E","volume":"2","author":"H Bian","year":"2025","unstructured":"Bian, H. et al. CD133-guided RNA nanoparticle delivery of FTO siRNA impairs leukemia resistance to tyrosine kinase inhibitor therapy. RNA Nanomed. 2, 70\u201388 (2025).","journal-title":"RNA Nanomed."},{"key":"1306_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.59566\/ISRNN.2024.0101079","volume":"1","author":"D Beasock","year":"2024","unstructured":"Beasock, D. et al. The reduction of traumatic spinal cord secondary injury by anti-RhoA siRNA functionalized nucleic acid nanoparticles (NANPs). RNA Nanomed. 1, 79\u201390 (2024).","journal-title":"RNA Nanomed."},{"key":"1306_CR37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1089\/hum.2017.054","volume":"29","author":"DL Jasinski","year":"2018","unstructured":"Jasinski, D. L., Yin, H., Li, Z. & Guo, P. Hydrophobic effect from conjugated chemicals or drugs on in vivo biodistribution of RNA nanoparticles. Hum. Gene Ther. 29, 77\u201386 (2018).","journal-title":"Hum. Gene Ther."},{"key":"1306_CR38","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.ymthe.2017.12.018","volume":"26","author":"DL Jasinski","year":"2018","unstructured":"Jasinski, D. L., Li, H. & Guo, P. The effect of size and shape of RNA nanoparticles on biodistribution. Mol. Ther. 26, 784\u2013792 (2018).","journal-title":"Mol. Ther."},{"key":"1306_CR39","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1021\/acs.molpharmaceut.1c00035","volume":"18","author":"H Wang","year":"2021","unstructured":"Wang, H. & Guo, P. Radiolabeled RNA nanoparticles for highly specific targeting and efficient tumor accumulation with favorable in vivo biodistribution. Mol. Pharm. 18, 2924\u20132934 (2021).","journal-title":"Mol. Pharm."},{"key":"1306_CR40","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1021\/ar500076k","volume":"47","author":"WW Grabow","year":"2014","unstructured":"Grabow, W. W. & Jaeger, L. RNA self-assembly and RNA nanotechnology. Acc. Chem. Res. 47, 1871\u20131880 (2014).","journal-title":"Acc. Chem. Res."},{"key":"1306_CR41","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/s41467-020-14780-5","volume":"11","author":"S Guo","year":"2020","unstructured":"Guo, S. et al. Ultra-thermostable RNA nanoparticles for solubilizing and high-yield loading of paclitaxel for breast cancer therapy. Nat. Commun. 11, 972\u2013982 (2020).","journal-title":"Nat. Commun."},{"key":"1306_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201900951","volume":"6","author":"X Piao","year":"2019","unstructured":"Piao, X., Yin, H., Guo, S., Wang, H. & Guo, P. RNA nanotechnology to solubilize ydrophobic antitumor drug for targeted delivery. Adv. Sci. 6, 1900951 (2019).","journal-title":"Adv. Sci."},{"key":"1306_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122432","volume":"305","author":"X Li","year":"2023","unstructured":"Li, X. et al. RNA four-way junction (4WJ) for spontaneous cancer-targeting, effective tumor-regression, metastasis suppression, fast renal excretion and undetectable toxicity. Biomaterials 305, 122432 (2023).","journal-title":"Biomaterials"},{"key":"1306_CR44","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1021\/acs.molpharmaceut.3c00845","volume":"21","author":"K Jin","year":"2024","unstructured":"Jin, K. et al. In vitro and in vivo evaluation of the pathology and safety aspects of three- and four-way junction RNA nanoparticles. Mol. Pharm. 21, 718\u2013728 (2024).","journal-title":"Mol. Pharm."},{"key":"1306_CR45","first-page":"33","volume":"2","author":"Y Che","year":"2025","unstructured":"Che, Y. et al. Targeting EGFR self-assembling RNA nanoparticles co-delivering paclitaxel and miRNA21 inhibitors for the treatment of head and neck tumors RNA. Nanomed 2, 33\u201351 (2025).","journal-title":"Nanomed"},{"key":"1306_CR46","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1021\/acsnano.6b05737","volume":"11","author":"D Jasinski","year":"2017","unstructured":"Jasinski, D., Haque, F., Binzel, D. W. & Guo, P. Advancement of the emerging field of RNA nanotechnology. ACS Nano 11, 1142\u20131164 (2017).","journal-title":"ACS Nano"},{"key":"1306_CR47","doi-asserted-by":"publisher","first-page":"5662","DOI":"10.1021\/nl502385k","volume":"14","author":"KA Afonin","year":"2014","unstructured":"Afonin, K. A. et al. Multifunctional RNA nanoparticles. Nano Lett. 14, 5662\u20135671 (2014).","journal-title":"Nano Lett."},{"key":"1306_CR48","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.copbio.2019.12.016","volume":"63","author":"J Kim","year":"2020","unstructured":"Kim, J. & Franco, E. RNA nanotechnology in synthetic biology. Curr. Opin. Biotechnol. 63, 135\u2013141 (2020).","journal-title":"Curr. Opin. Biotechnol."},{"key":"1306_CR49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1261\/rna.063057.117","volume":"24","author":"X Piao","year":"2018","unstructured":"Piao, X., Wang, H., Binzel, D. W. & Guo, P. Assessment and comparison of Thermal stability of phosphorothioate-DNA, DNA, RNA, 2\u2032-F RNA, and LNA in the context of Phi29 pRNA 3WJ. RNA 24, 67\u201376 (2018).","journal-title":"RNA"},{"key":"1306_CR50","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3389\/fncel.2017.00336","volume":"11","author":"LC Huang","year":"2017","unstructured":"Huang, L. C. et al. Nicotinic acetylcholine receptor subtype alpha-9 mediates triple-negative breast cancers based on a spontaneous pulmonary metastasis mouse model. Front. Cell. Neurosci. 11, 336 (2017).","journal-title":"Front. Cell. Neurosci."},{"key":"1306_CR51","doi-asserted-by":"publisher","first-page":"9996","DOI":"10.1093\/nar\/gku516","volume":"42","author":"EF Khisamutdinov","year":"2014","unstructured":"Khisamutdinov, E. F. et al. Enhancing immunomodulation on innate immunity by shape transition among RNA triangle, square and pentagon nanovehicles. Nucleic Acids Res. 42, 9996\u201310004 (2014).","journal-title":"Nucleic Acids Res."},{"key":"1306_CR52","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.omtn.2017.10.010","volume":"9","author":"S Guo","year":"2017","unstructured":"Guo, S. et al. Size, shape, and sequence-dependent immunogenicity of RNA nanoparticles. Mol. Ther. Nucleic Acids 9, 399\u2013408 (2017).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1306_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201805959","volume":"28","author":"L Rackley","year":"2018","unstructured":"Rackley, L. et al. RNA fibers as optimized nanoscaffolds for siRNA coordination and reduced immunological recognition. Adv. Funct. Mater. 28, 1805959 (2018).","journal-title":"Adv. Funct. Mater."},{"key":"1306_CR54","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3390\/nano9040611","volume":"9","author":"M Chandler","year":"2019","unstructured":"Chandler, M. & Afonin, K. A. Smart-responsive nucleic acid nanoparticles (NANPs) with the potential to modulate immune behavior. Nanomaterials 9, 611 (2019).","journal-title":"Nanomaterials"},{"key":"1306_CR55","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1089\/hum.2005.16.1097","volume":"16","author":"S Guo","year":"2005","unstructured":"Guo, S., Tschammer, N., Mohammed, S. & Guo, P. Specific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNA. Hum. Gene Ther. 16, 1097\u20131109 (2005).","journal-title":"Hum. Gene Ther."},{"key":"1306_CR56","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/mt.2011.23","volume":"19","author":"Y Shu","year":"2011","unstructured":"Shu, Y., Cinier, M., Fox, S. R., Ben-Johnathan, N. & Guo, P. Assembly of therapeutic pRNA-siRNA nanoparticles using bipartite approach. Mol. Ther. 19, 1304\u20131311 (2011).","journal-title":"Mol. Ther."},{"key":"1306_CR57","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nnano.2011.105","volume":"6","author":"D Shu","year":"2011","unstructured":"Shu, D., Shu, Y., Haque, F., Abdelmawla, S. & Guo, P. Thermodynamically stable RNA three-way junction for constructing multifunctional nanoparticles for delivery of therapeutics. Nat. Nanotechnol. 6, 658\u2013667 (2011).","journal-title":"Nat. Nanotechnol."},{"key":"1306_CR58","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.nano.2015.11.008","volume":"12","author":"A Sharma","year":"2016","unstructured":"Sharma, A. et al. Controllable self-assembly of RNA dendrimers. Nanomedicine 12, 835\u2013844 (2016).","journal-title":"Nanomedicine"},{"key":"1306_CR59","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1007\/s12274-019-2463-z","volume":"12","author":"H Li","year":"2019","unstructured":"Li, H. et al. Construction of RNA nanotubes. Nano Res. 12, 1952\u20131958 (2019).","journal-title":"Nano Res."},{"key":"1306_CR60","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1080\/15476286.2021.1915620","volume":"18","author":"H Li","year":"2021","unstructured":"Li, H. et al. RNA nanotechnology to build a dodecahedral genome of single-stranded RNA virus. RNA Biol. 18, 2390\u20132400 (2021).","journal-title":"RNA Biol."},{"key":"1306_CR61","doi-asserted-by":"publisher","first-page":"7620","DOI":"10.1021\/nn502160s","volume":"8","author":"DL Jasinski","year":"2014","unstructured":"Jasinski, D. L., Khisamutdinov, E. F., Lyubchenko, Y. L. & Guo, P. Physicochemically tunable polyfunctionalized RNA square architecture with fluorogenic and ribozymatic properties. ACS Nano 8, 7620\u20137629 (2014).","journal-title":"ACS Nano"},{"key":"1306_CR62","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1021\/nn5006254","volume":"8","author":"EF Khisamutdinov","year":"2014","unstructured":"Khisamutdinov, E. F., Jasinski, D. L. & Guo, P. RNA as a boiling-resistant anionic polymer material to build robust structures with defined shape and stoichiometry. ACS Nano 8, 4771\u20134781 (2014).","journal-title":"ACS Nano"},{"key":"1306_CR63","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/978-1-4939-2730-2_15","volume":"1316","author":"EF Khisamutdinov","year":"2015","unstructured":"Khisamutdinov, E. F. et al. Simple method for constructing RNA triangle, square, pentagon by tuning interior RNA 3WJ angle from 60 degrees to 90 degrees or 108 degrees. Methods Mol. Biol. 1316, 181\u2013193 (2015).","journal-title":"Methods Mol. Biol."},{"key":"1306_CR64","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jconrel.2018.02.014","volume":"276","author":"Y Shu","year":"2018","unstructured":"Shu, Y. et al. RNA-based micelles: a novel platform for paclitaxel loading and delivery. J. Control. Release 276, 17\u201329 (2018).","journal-title":"J. Control. Release"},{"key":"1306_CR65","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/smll.201302676","volume":"10","author":"KE Shopsowitz","year":"2014","unstructured":"Shopsowitz, K. E., Roh, Y. H., Deng, Z. J., Morton, S. W. & Hammond, P. T. RNAi-microsponges form through self-assembly of the organic and inorganic products of transcription. Small 10, 1623\u20131633 (2014).","journal-title":"Small"},{"key":"1306_CR66","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.nano.2016.12.018","volume":"13","author":"MN Bui","year":"2017","unstructured":"Bui, M. N. et al. Versatile RNA tetra-U helix linking motif as a toolkit for nucleic acid nanotechnology. Nanomedicine 13, 1137\u20131146 (2017).","journal-title":"Nanomedicine"},{"key":"1306_CR67","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1039\/C9NR08197F","volume":"12","author":"P Zakrevsky","year":"2020","unstructured":"Zakrevsky, P. et al. Truncated tetrahedral RNA nanostructures exhibit enhanced features for delivery of RNAi substrates. Nanoscale 12, 2555\u20132568 (2020).","journal-title":"Nanoscale"},{"key":"1306_CR68","doi-asserted-by":"publisher","first-page":"281","DOI":"10.7150\/thno.35568","volume":"10","author":"YX Lin","year":"2020","unstructured":"Lin, Y. X. et al. RNA nanotechnology-mediated cancer immunotherapy. Theranostics 10, 281\u2013299 (2020).","journal-title":"Theranostics"},{"key":"1306_CR69","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/nar\/29.2.455","volume":"29","author":"L Jaeger","year":"2001","unstructured":"Jaeger, L., Westhof, E. & Leontis, N. B. TectoRNA: modular assembly units for the construction of RNA nano-objects. Nucleic Acids Res. 29, 455\u2013463 (2001).","journal-title":"Nucleic Acids Res."},{"key":"1306_CR70","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1038\/nprot.2013.097","volume":"8","author":"Y Shu","year":"2013","unstructured":"Shu, Y., Shu, D., Haque, F. & Guo, P. Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells. Nat. Protoc. 8, 1635\u20131659 (2013).","journal-title":"Nat. Protoc."},{"key":"1306_CR71","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1261\/rna.037002.112","volume":"19","author":"Y Shu","year":"2013","unstructured":"Shu, Y. et al. Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs. RNA 19, 767\u2013777 (2013).","journal-title":"RNA"},{"key":"1306_CR72","doi-asserted-by":"publisher","first-page":"14766","DOI":"10.18632\/oncotarget.3632","volume":"6","author":"TJ Lee","year":"2015","unstructured":"Lee, T. J. et al. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model. Oncotarget 6, 14766\u201314776 (2015).","journal-title":"Oncotarget"},{"key":"1306_CR73","doi-asserted-by":"publisher","first-page":"10726","DOI":"10.1038\/srep10726","volume":"5","author":"D Cui","year":"2015","unstructured":"Cui, D. et al. Regression of gastric cancer by systemic injection of RNA nanoparticles carrying both ligand and siRNA. Sci. Rep. 5, 10726\u201310739 (2015).","journal-title":"Sci. Rep."},{"key":"1306_CR74","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1021\/acsnano.5b00067","volume":"9","author":"P Rychahou","year":"2015","unstructured":"Rychahou, P. et al. Delivery of RNA nanoparticles into colorectal cancer metastases following systemic administration. ACS Nano 9, 1108\u20131116 (2015).","journal-title":"ACS Nano"},{"key":"1306_CR75","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1021\/acsnano.6b05910","volume":"11","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Overcoming tamoxifen resistance of human breast cancer by targeted gene silencing using multifunctional pRNA nanoparticles. ACS Nano 11, 335\u2013346 (2017).","journal-title":"ACS Nano"},{"key":"1306_CR76","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/j.ymthe.2016.11.016","volume":"25","author":"TJ Lee","year":"2017","unstructured":"Lee, T. J. et al. RNA nanoparticle-based targeted therapy for glioblastoma through inhibition of oncogenic miR-21. Mol. Ther. 25, 1544\u20131555 (2017).","journal-title":"Mol. Ther."},{"key":"1306_CR77","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.omtn.2020.08.024","volume":"22","author":"L Pang","year":"2020","unstructured":"Pang, L. et al. EpCAM-targeted 3WJ RNA nanoparticle harboring delta-5-desaturase siRNA inhibited lung tumor formation via DGLA peroxidation. Mol. Ther. Nucleic Acids 22, 222\u2013235 (2020).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1306_CR78","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/S0040-4039(01)90461-7","volume":"22","author":"SL Beaucage","year":"1981","unstructured":"Beaucage, S. L. & Caruthers, M. H. Deoxynucleoside phosphoramidites\u2014a new class of key intermediates for deoxypolynucleotide synthesis. Tetrahedron Lett. 22, 1859\u20131862 (1981).","journal-title":"Tetrahedron Lett."},{"key":"1306_CR79","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1016\/S0040-4020(01)88752-4","volume":"48","author":"SL Beaucage","year":"1992","unstructured":"Beaucage, S. L. & Iyer, R. P. Advances in the synthesis of oligonucleotides by the phosphoramidite approach. Tetrehedron 48, 2223\u20132311 (1992).","journal-title":"Tetrehedron"},{"key":"1306_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202403063","volume":"63","author":"L Flemmich","year":"2024","unstructured":"Flemmich, L., Bereiter, R. & Micura, R. Chemical synthesis of modified RNA. Angew. Chem. Int. Ed. Engl. 63, e202403063 (2024).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"1306_CR81","first-page":"1","volume":"20","author":"DM Brown","year":"1993","unstructured":"Brown, D. M. A brief history of oligonucleotide synthesis. Methods Mol. Biol. 20, 1\u201317 (1993).","journal-title":"Methods Mol. Biol."},{"key":"1306_CR82","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5","volume":"40","author":"HC Kolb","year":"2001","unstructured":"Kolb, H. C., Finn, M. G. & Sharpless, K. B. Click chemistry: diverse chemical function from a few good reactions. Angew. Chem. Int. Ed. Engl. 40, 2004\u20132021 (2001).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"1306_CR83","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1017\/S0033583522000129","volume":"55","author":"T Brown","year":"2022","unstructured":"Brown, T. & Norden, B. Nobel Prize 2022 to Sharpless, Meldal, Bertozzi Click Chemistry - molecular lego. Q. Rev. Biophys. 55, e13 (2022).","journal-title":"Q. Rev. Biophys."},{"key":"1306_CR84","unstructured":"Huisgen, R. Centenary lecture - 1,3-dipolar cycloadditions. Proc. Chem. Soc. 357\u2013396 (1961)."},{"key":"1306_CR85","doi-asserted-by":"publisher","first-page":"6971","DOI":"10.1021\/bi0029548","volume":"40","author":"JM Diamond","year":"2001","unstructured":"Diamond, J. M., Turner, D. H. & Mathews, D. H. Thermodynamics of three-way multibranch loops in RNA. Biochemistry 40, 6971\u20136981 (2001).","journal-title":"Biochemistry"},{"key":"1306_CR86","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1261\/rna.037077.112","volume":"19","author":"H Zhang","year":"2013","unstructured":"Zhang, H. et al. Crystal structure of 3WJ core revealing divalent ion-promoted thermostability and assembly of the Phi29 hexameric motor pRNA. RNA 19, 1226\u20131237 (2013).","journal-title":"RNA"},{"key":"1306_CR87","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1021\/acssynbio.8b00319","volume":"8","author":"D Jedrzejczyk","year":"2019","unstructured":"Jedrzejczyk, D. & Chworos, A. Self-assembling RNA nanoparticle for gene expression regulation in a model system. ACS Synth. Biol. 8, 491\u2013497 (2019).","journal-title":"ACS Synth. Biol."},{"key":"1306_CR88","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/0092-8674(95)90218-X","volume":"83","author":"DR Duckett","year":"1995","unstructured":"Duckett, D. R., Murchie, A. I. & Lilley, D. M. The global folding of four-way helical junctions in RNA, including that in U1 snRNA. Cell 83, 1027\u20131036 (1995).","journal-title":"Cell"},{"key":"1306_CR89","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.nantod.2012.06.010","volume":"7","author":"F Haque","year":"2012","unstructured":"Haque, F. et al. Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers. Nano Today 7, 245\u2013257 (2012).","journal-title":"Nano Today"},{"key":"1306_CR90","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1021\/nl900261h","volume":"9","author":"I Severcan","year":"2009","unstructured":"Severcan, I., Geary, C., Verzemnieks, E., Chworos, A. & Jaeger, L. Square-shaped RNA particles from different RNA folds. Nano Lett. 9, 1270\u20131277 (2009).","journal-title":"Nano Lett."},{"key":"1306_CR91","doi-asserted-by":"publisher","first-page":"6405","DOI":"10.1073\/pnas.1017999108","volume":"108","author":"SM Dibrov","year":"2011","unstructured":"Dibrov, S. M., McLean, J., Parsons, J. & Hermann, T. Self-assembling RNA square. Proc. Natl Acad. Sci. USA. 108, 6405\u20136408 (2011).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"1306_CR92","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-1-4939-7138-1_2","volume":"1632","author":"R Sharan","year":"2017","unstructured":"Sharan, R., Bindewald, E., Kasprzak, W. K. & Shapiro, B. A. Computational generation of RNA nanorings. Methods Mol. Biol. 1632, 19\u201332 (2017).","journal-title":"Methods Mol. Biol."},{"key":"1306_CR93","first-page":"451","volume":"161","author":"H Oi","year":"2017","unstructured":"Oi, H. et al. Programmable formation of catalytic RNA triangles and squares by assembling modular RNA enzymes. J. Biochem. 161, 451\u2013462 (2017).","journal-title":"J. Biochem."},{"key":"1306_CR94","doi-asserted-by":"publisher","first-page":"7501","DOI":"10.1002\/adma.201601976","volume":"28","author":"H Li","year":"2016","unstructured":"Li, H. et al. Controllable self-assembly of RNA tetrahedrons with precise shape and size for cancer targeting. Adv. Mater. 28, 7501\u20137507 (2016).","journal-title":"Adv. Mater."},{"key":"1306_CR95","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/bs.mie.2014.10.050","volume":"553","author":"KJ Purzycka","year":"2015","unstructured":"Purzycka, K. J. et al. Automated 3D RNA structure prediction using the RNAComposer method for riboswitches. Methods Enzymol. 553, 3\u201334 (2015).","journal-title":"Methods Enzymol."},{"key":"1306_CR96","doi-asserted-by":"publisher","first-page":"10079","DOI":"10.1002\/adma.201603180","volume":"28","author":"EF Khisamutdinov","year":"2016","unstructured":"Khisamutdinov, E. F. et al. Fabrication of RNA 3D nanoprisms for loading and protection of small RNAs and model drugs. Adv. Mater. 28, 10079\u201310087 (2016).","journal-title":"Adv. Mater."},{"key":"1306_CR97","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1021\/acsnano.8b07948","volume":"13","author":"H Yin","year":"2019","unstructured":"Yin, H., Wang, H., Li, Z., Shu, D. & Guo, P. RNA micelles for the systemic delivery of anti-miRNA for cancer targeting and inhibition without ligand. ACS Nano 13, 706\u2013717 (2019).","journal-title":"ACS Nano"},{"key":"1306_CR98","doi-asserted-by":"publisher","first-page":"e24071","DOI":"10.1371\/journal.pone.0024071","volume":"6","author":"CL Esposito","year":"2011","unstructured":"Esposito, C. L. et al. A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death. PLoS ONE 6, e24071 (2011).","journal-title":"PLoS ONE"},{"key":"1306_CR99","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/j.1349-7006.2011.01897.x","volume":"102","author":"S Shigdar","year":"2011","unstructured":"Shigdar, S. et al. RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule. Cancer Sci. 102, 991\u2013998 (2011).","journal-title":"Cancer Sci."},{"key":"1306_CR100","doi-asserted-by":"publisher","first-page":"794","DOI":"10.2165\/00003495-199448050-00009","volume":"48","author":"CM Spencer","year":"1994","unstructured":"Spencer, C. M. & Faulds, D. Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer. Drugs 48, 794\u2013847 (1994).","journal-title":"Drugs"},{"key":"1306_CR101","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i4.10","volume":"26","author":"S Singh","year":"2009","unstructured":"Singh, S. & Dash, A. K. Paclitaxel in cancer treatment: perspectives and prospects of its delivery challenges. Crit. Rev. Ther. Drug Carr. Syst. 26, 333\u2013372 (2009).","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"1306_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104398","volume":"148","author":"C Bailly","year":"2019","unstructured":"Bailly, C. Irinotecan: 25 years of cancer treatment. Pharmacol. Res. 148, 104398 (2019).","journal-title":"Pharmacol. Res."},{"key":"1306_CR103","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1021\/cr60284a004","volume":"73","author":"AG Schultz","year":"1973","unstructured":"Schultz, A. G. Camptothecin. Chem. Rev. 73, 385\u2013405 (1973).","journal-title":"Chem. Rev."},{"key":"1306_CR104","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1749-6632.1996.tb26391.x","volume":"803","author":"FM Muggia","year":"1996","unstructured":"Muggia, F. M., Dimery, I. & Arbuck, S. G. Camptothecin and its analogs. An overview of their potential in cancer therapeutics. Ann. N. Y. Acad. Sci. 803, 213\u2013223 (1996).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1306_CR105","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/anie.197805221","volume":"17","author":"B Neises","year":"1978","unstructured":"Neises, B. & Steglich, W. Simple method for the esterification of carboxylic acids. Angew. Chem. Int. Ed. Engl. 17, 522\u2013524 (1978).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"1306_CR106","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nnano.2007.387","volume":"2","author":"D Peer","year":"2007","unstructured":"Peer, D. et al. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751\u2013760 (2007).","journal-title":"Nat. Nanotechnol."},{"key":"1306_CR107","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0022-2836(65)80093-6","volume":"13","author":"AD Bangham","year":"1965","unstructured":"Bangham, A. D., Standish, M. M. & Watkins, J. C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 13, 238\u2013252 (1965).","journal-title":"J. Mol. Biol."},{"key":"1306_CR108","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1021\/acsmaterialsau.3c00032","volume":"3","author":"M Mehta","year":"2023","unstructured":"Mehta, M. et al. Lipid-based nanoparticles for drug\/gene delivery: an overview of the production techniques and difficulties encountered in their industrial development. ACS Mater. Au 3, 600\u2013619 (2023).","journal-title":"ACS Mater. Au"},{"key":"1306_CR109","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1124\/pr.115.012070","volume":"68","author":"P Yingchoncharoen","year":"2016","unstructured":"Yingchoncharoen, P., Kalinowski, D. S. & Richardson, D. R. Lipid-based drug delivery systems in cancer therapy: what is available and what is yet to come. Pharmacol. Rev. 68, 701\u2013787 (2016).","journal-title":"Pharmacol. Rev."},{"key":"1306_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e09403","volume":"8","author":"S Sheoran","year":"2022","unstructured":"Sheoran, S., Arora, S., Samsonraj, R., Govindaiah, P. & Vuree, S. Lipid-based nanoparticles for treatment of cancer. Heliyon 8, e09403 (2022).","journal-title":"Heliyon"},{"key":"1306_CR111","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1517\/17425247.2012.685933","volume":"9","author":"X Lin","year":"2012","unstructured":"Lin, X. et al. Lipid nanoparticles for chemotherapeutic applications: strategies to improve anticancer efficacy. Expert Opin. Drug Deliv. 9, 767\u2013781 (2012).","journal-title":"Expert Opin. Drug Deliv."},{"key":"1306_CR112","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/pharmaceutics12030288","volume":"12","author":"M Haider","year":"2020","unstructured":"Haider, M., Abdin, S. M., Kamal, L. & Orive, G. Nanostructured lipid carriers for delivery of chemotherapeutics: a review. Pharmaceutics 12, 288 (2020).","journal-title":"Pharmaceutics"},{"key":"1306_CR113","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202100639","volume":"11","author":"L van der Koog","year":"2022","unstructured":"van der Koog, L., Gandek, T. B. & Nagelkerke, A. Liposomes and extracellular vesicles as drug delivery systems: a comparison of composition, pharmacokinetics, and functionalization. Adv. Healthc. Mater. 11, e2100639 (2022).","journal-title":"Adv. Healthc. Mater."},{"key":"1306_CR114","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fphar.2015.00286","volume":"6","author":"L Sercombe","year":"2015","unstructured":"Sercombe, L. et al. Advances and challenges of liposome assisted drug delivery. Front. Pharmacol. 6, 286 (2015).","journal-title":"Front. Pharmacol."},{"key":"1306_CR115","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/nano10020190","volume":"10","author":"CT Inglut","year":"2020","unstructured":"Inglut, C. T. et al. Immunological and toxicological considerations for the design of liposomes. Nanomaterials 10, 190 (2020).","journal-title":"Nanomaterials"},{"key":"1306_CR116","doi-asserted-by":"publisher","unstructured":"Alavi, M. & Hamidi, M. Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles. Drug Metab Pers Ther. https:\/\/doi.org\/10.1515\/dmpt-2018-0032 (2019).","DOI":"10.1515\/dmpt-2018-0032"},{"key":"1306_CR117","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3390\/nano9040638","volume":"9","author":"B Garcia-Pinel","year":"2019","unstructured":"Garcia-Pinel, B. et al. Lipid-based nanoparticles: application and recent advances in cancer treatment. Nanomaterials 9, 638 (2019).","journal-title":"Nanomaterials"},{"key":"1306_CR118","first-page":"226","volume":"51","author":"HA Yousefi Rizi","year":"2022","unstructured":"Yousefi Rizi, H. A., Hoon Shin, D. & Yousefi Rizi, S. Polymeric nanoparticles in cancer chemotherapy: a narrative review. Iran. J. Public Health 51, 226\u2013239 (2022).","journal-title":"Iran. J. Public Health"},{"key":"1306_CR119","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41467-018-03705-y","volume":"22","author":"D Rosenblum","year":"2018","unstructured":"Rosenblum, D., Joshi, N., Tao, W., Karp, J.M. & Peer, D. Progress and challenges towards targeted delivery of cancer therapeutics. Nat Commun. 22, 1410 (2018).","journal-title":"Nat Commun."},{"key":"1306_CR120","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","volume":"124","author":"MA Beach","year":"2024","unstructured":"Beach, M. A. et al. Polymeric nanoparticles for drug delivery. Chem. Rev. 124, 5505\u20135616 (2024).","journal-title":"Chem. Rev."},{"key":"1306_CR121","volume":"32","author":"N Salari","year":"2022","unstructured":"Salari, N. et al. Polymer-based drug delivery systems for anticancer drugs: a systematic review. Cancer Treat. Res. Commun. 32, 100605 (2022).","journal-title":"Cancer Treat. Res. Commun."},{"key":"1306_CR122","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1021\/accountsmr.1c00178","volume":"3","author":"AS Shah","year":"2022","unstructured":"Shah, A. S., Surnar, B., Kolishetti, N. & Dhar, S. Intersection of inorganic chemistry and nanotechnology for the creation of new cancer therapies. Acc. Mater. Res. 3, 283\u2013296 (2022).","journal-title":"Acc. Mater. Res."},{"key":"1306_CR123","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1039\/D3TB00226H","volume":"11","author":"M Khorenko","year":"2023","unstructured":"Khorenko, M. et al. Theranostic inorganic-organic hybrid nanoparticles with a cocktail of chemotherapeutic and cytostatic drugs. J. Mater. Chem. B 11, 3635\u20133649 (2023).","journal-title":"J. Mater. Chem. B"},{"key":"1306_CR124","doi-asserted-by":"publisher","DOI":"10.1177\/15330338231192850","volume":"22","author":"F Barbero","year":"2023","unstructured":"Barbero, F., Gul, S., Perrone, G. & Fenoglio, I. Photoresponsive inorganic nanomaterials in oncology. Technol. Cancer Res. Treat. 22, 15330338231192850 (2023).","journal-title":"Technol. Cancer Res. Treat."},{"key":"1306_CR125","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3390\/pharmaceutics14030660","volume":"14","author":"AM Alkilany","year":"2022","unstructured":"Alkilany, A. M. et al. PLGA-gold nanocomposite: preparation and biomedical applications. Pharmaceutics 14, 660 (2022).","journal-title":"Pharmaceutics"},{"key":"1306_CR126","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.addr.2018.07.011","volume":"130","author":"EN Hoogenboezem","year":"2018","unstructured":"Hoogenboezem, E. N. & Duvall, C. L. Harnessing albumin as a carrier for cancer therapies. Adv. Drug Deliv. Rev. 130, 73\u201389 (2018).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"1306_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.890412","volume":"9","author":"L Kong","year":"2022","unstructured":"Kong, L. et al. Gemcitabine-loaded albumin nanoparticle exerts an antitumor effect on gemcitabine-resistant pancreatic cancer cells induced by MDR1 and MRP1 overexpression in vitro. Front. Surg. 9, 890412 (2022).","journal-title":"Front. Surg."},{"key":"1306_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2022.112422","volume":"213","author":"SS Kunde","year":"2022","unstructured":"Kunde, S. S. & Wairkar, S. Targeted delivery of albumin nanoparticles for breast cancer: a review. Colloids Surf. B Biointerfaces 213, 112422 (2022).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"1306_CR129","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1586\/14737140.2014.881719","volume":"14","author":"V Hirsh","year":"2014","unstructured":"Hirsh, V. nab-paclitaxel for the management of patients with advanced non-small-cell lung cancer. Expert Rev. Anticancer Ther. 14, 129\u2013141 (2014).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"1306_CR130","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1517\/14656566.7.8.1041","volume":"7","author":"WJ Gradishar","year":"2006","unstructured":"Gradishar, W. J. Albumin-bound paclitaxel: a next-generation taxane. Expert Opin. Pharmacother. 7, 1041\u20131053 (2006).","journal-title":"Expert Opin. Pharmacother."},{"key":"1306_CR131","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-57380-0","volume":"10","author":"H Lee","year":"2020","unstructured":"Lee, H. et al. Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with solvent-based taxanes for metastatic breast cancer: a meta-analysis. Sci. Rep. 10, 530 (2020).","journal-title":"Sci. Rep."},{"key":"1306_CR132","first-page":"e39872","volume":"15","author":"SA Alhebshi","year":"2023","unstructured":"Alhebshi, S. A. et al. Toxicity of nab-paclitaxel compared to paclitaxel in a tertiary hospital in Jeddah, Saudi Arabia: a retrospective cohort study. Cureus 15, e39872 (2023).","journal-title":"Cureus"},{"key":"1306_CR133","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41573-023-00709-2","volume":"22","author":"C Dumontet","year":"2023","unstructured":"Dumontet, C., Reichert, J. M., Senter, P. D., Lambert, J. M. & Beck, A. Antibody-drug conjugates come of age in oncology. Nat. Rev. Drug Discov. 22, 641\u2013661 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1306_CR134","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0140-6736(19)31774-X","volume":"394","author":"CH Chau","year":"2019","unstructured":"Chau, C. H., Steeg, P. S. & Figg, W. D. Antibody-drug conjugates for cancer. Lancet 394, 793\u2013804 (2019).","journal-title":"Lancet"},{"key":"1306_CR135","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1146\/annurev-biochem-060308-102244","volume":"79","author":"NC Seeman","year":"2010","unstructured":"Seeman, N. C. Nanomaterials based on DNA. Annu. Rev. Biochem. 79, 65\u201387 (2010).","journal-title":"Annu. Rev. Biochem."},{"key":"1306_CR136","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0022-5193(82)90002-9","volume":"99","author":"NC Seeman","year":"1982","unstructured":"Seeman, N. C. Nucleic acid junctions and lattices. J. Theor. Biol. 99, 237\u2013247 (1982).","journal-title":"J. Theor. Biol."},{"key":"1306_CR137","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nature04586","volume":"440","author":"PW Rothemund","year":"2006","unstructured":"Rothemund, P. W. Folding DNA to create nanoscale shapes and patterns. Nature 440, 297\u2013302 (2006).","journal-title":"Nature"},{"key":"1306_CR138","doi-asserted-by":"publisher","DOI":"10.1038\/natrevmats.2017.68","volume":"3","author":"N Seeman","year":"2017","unstructured":"Seeman, N. & Sleiman, H. DNA nanotechnology. Nat. Rev. Mater. 3, 17068 (2017).","journal-title":"Nat. Rev. Mater."},{"key":"1306_CR139","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2116\/analsci.20SAR18","volume":"37","author":"S Saito","year":"2021","unstructured":"Saito, S. SELEX-based DNA aptamer selection: a perspective from the advancement of separation techniques. Anal. Sci. 37, 17\u201326 (2021).","journal-title":"Anal. Sci."},{"key":"1306_CR140","doi-asserted-by":"publisher","first-page":"13396","DOI":"10.1021\/ja304263n","volume":"134","author":"Q Jiang","year":"2012","unstructured":"Jiang, Q. et al. DNA origami as a carrier for circumvention of drug resistance. J. Am. Chem. Soc. 134, 13396\u201313403 (2012).","journal-title":"J. Am. Chem. Soc."},{"key":"1306_CR141","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202300424","volume":"24","author":"J Wang","year":"2023","unstructured":"Wang, J. et al. DNA nanobarrel-based drug delivery for paclitaxel and doxorubicin. Chembiochem 24, e202300424 (2023).","journal-title":"Chembiochem"},{"key":"1306_CR142","doi-asserted-by":"publisher","first-page":"6962","DOI":"10.1021\/nn201446c","volume":"5","author":"XQ Zhang","year":"2011","unstructured":"Zhang, X. Q. et al. Strategy for increasing drug solubility and efficacy through covalent attachment to polyvalent DNA-nanoparticle conjugates. ACS Nano 5, 6962\u20136970 (2011).","journal-title":"ACS Nano"},{"key":"1306_CR143","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1038\/ncomms4890","volume":"5","author":"C Hao","year":"2014","unstructured":"Hao, C. et al. Construction of RNA nanocages by re-engineering the packaging RNA of Phi29 bacteriophage. Nat. Commun. 5, 3890\u20133897 (2014).","journal-title":"Nat. Commun."},{"key":"1306_CR144","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6724","volume":"6","author":"J Yu","year":"2015","unstructured":"Yu, J., Liu, Z., Jiang, W., Wang, G. & Mao, C. De novo design of an RNA tile that self-assembles into a homo-octameric nanoprism. Nat. Commun. 6, 5724 (2015).","journal-title":"Nat. Commun."},{"key":"1306_CR145","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nchem.733","volume":"2","author":"I Severcan","year":"2010","unstructured":"Severcan, I. et al. A polyhedron made of tRNAs. Nat. Chem. 2, 772\u2013779 (2010).","journal-title":"Nat. Chem."},{"key":"1306_CR146","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1021\/nl104271s","volume":"11","author":"WW Grabow","year":"2011","unstructured":"Grabow, W. W. et al. Self-assembling RNA nanorings based on RNAI\/II inverse cissing Complexes. Nano Lett. 11, 878\u2013887 (2011).","journal-title":"Nano Lett."},{"key":"1306_CR147","doi-asserted-by":"publisher","DOI":"10.1002\/biot.201700634","volume":"14","author":"HC Hoiberg","year":"2019","unstructured":"Hoiberg, H. C., Sparvath, S. M., Andersen, V. L., Kjems, J. & Andersen, E. S. An RNA origami octahedron with intrinsic siRNAs for potent gene knockdown. Biotechnol. J. 14, e1700634 (2019).","journal-title":"Biotechnol. J."},{"key":"1306_CR148","doi-asserted-by":"publisher","first-page":"17542","DOI":"10.1039\/C6NR05085A","volume":"8","author":"JM Stewart","year":"2016","unstructured":"Stewart, J. M. et al. Programmable RNA microstructures for coordinated delivery of siRNAs. Nanoscale 8, 17542\u201317550 (2016).","journal-title":"Nanoscale"},{"key":"1306_CR149","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nnano.2010.160","volume":"5","author":"KA Afonin","year":"2010","unstructured":"Afonin, K. A. et al. In vitro assembly of cubic RNA-based scaffolds designed in silico. Nat. Nanotechnol. 5, 676\u2013682 (2010).","journal-title":"Nat. Nanotechnol."},{"key":"1306_CR150","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.3390\/molecules26144231","volume":"26","author":"D Bila","year":"2021","unstructured":"Bila, D., Radwan, Y., Dobrovolskaia, M. A., Panigaj, M. & Afonin, K. A. The recognition of and reactions to nucleic acid nanoparticles by human immune cells. Molecules 26, 4231 (2021).","journal-title":"Molecules"},{"key":"1306_CR151","doi-asserted-by":"publisher","first-page":"16072","DOI":"10.1021\/ja0757982","volume":"129","author":"AL Hansen","year":"2007","unstructured":"Hansen, A. L. & Al-Hashimi, H. M. Dynamics of large elongated RNA by NMR carbon relaxation. J. Am. Chem. Soc. 129, 16072\u201316082 (2007).","journal-title":"J. Am. Chem. Soc."},{"key":"1306_CR152","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1021\/ja068391q","volume":"129","author":"L Zhao","year":"2007","unstructured":"Zhao, L. & Xia, T. Direct revelation of multiple conformations in RNA by femtosecond dynamics. J. Am. Chem. Soc. 129, 4118\u20134119 (2007).","journal-title":"J. Am. Chem. Soc."},{"key":"1306_CR153","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.cbpa.2008.09.033","volume":"12","author":"KB Hall","year":"2008","unstructured":"Hall, K. B. RNA in motion. Curr. Opin. Chem. Biol. 12, 612\u2013618 (2008).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"1306_CR154","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.sbi.2008.04.004","volume":"18","author":"HM Al-Hashimi","year":"2008","unstructured":"Al-Hashimi, H. M. & Walter, N. G. RNA dynamics: it is about time. Curr. Opin. Struct. Biol. 18, 321\u2013329 (2008).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"1306_CR155","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.nantod.2015.09.003","volume":"10","author":"H Li","year":"2015","unstructured":"Li, H. et al. RNA as a stable polymer to build controllable and defined nanostructures for material and biomedical applications. Nano Today 10, 631\u2013655 (2015).","journal-title":"Nano Today"},{"key":"1306_CR156","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/j.bbapap.2017.06.012","volume":"1865","author":"RWT Harkness","year":"2017","unstructured":"Harkness, R. W. T. & Mittermaier, A. K. G-quadruplex dynamics. Biochim. Biophys. Acta Proteins Proteom. 1865, 1544\u20131554 (2017).","journal-title":"Biochim. Biophys. Acta Proteins Proteom."},{"key":"1306_CR157","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/0014-5793(71)80223-5","volume":"13","author":"A Danchin","year":"1971","unstructured":"Danchin, A. A dynamic molecular model for transfer RNA. FEBS Lett. 13, 152\u2013156 (1971).","journal-title":"FEBS Lett."},{"key":"1306_CR158","doi-asserted-by":"publisher","first-page":"5095","DOI":"10.1073\/pnas.1701132114","volume":"114","author":"DR Jacobson","year":"2017","unstructured":"Jacobson, D. R., McIntosh, D. B., Stevens, M. J., Rubinstein, M. & Saleh, O. A. Single-stranded nucleic acid elasticity arises from internal electrostatic tension. Proc. Natl Acad. Sci. USA 114, 5095\u20135100 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1306_CR159","doi-asserted-by":"publisher","first-page":"8901","DOI":"10.1093\/nar\/gkaa654","volume":"48","author":"MC Hopfinger","year":"2020","unstructured":"Hopfinger, M. C., Kirkpatrick, C. C. & Znosko, B. M. Predictions and analyses of RNA nearest neighbor parameters for modified nucleotides. Nucleic Acids Res. 48, 8901\u20138913 (2020).","journal-title":"Nucleic Acids Res."},{"key":"1306_CR160","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1093\/nar\/gkz019","volume":"47","author":"MS Adams","year":"2019","unstructured":"Adams, M. S. & Znosko, B. M. Thermodynamic characterization and nearest neighbor parameters for RNA duplexes under molecular crowding conditions. Nucleic Acids Res. 47, 3658\u20133666 (2019).","journal-title":"Nucleic Acids Res."},{"key":"1306_CR161","doi-asserted-by":"publisher","first-page":"14719","DOI":"10.1021\/bi9809425","volume":"37","author":"T Xia","year":"1998","unstructured":"Xia, T. et al. Thermodynamic parameters for an expanded nearest-neighbor model for formation of RNA duplexes with Watson-Crick base pairs. Biochemistry 37, 14719\u201314735 (1998).","journal-title":"Biochemistry"},{"key":"1306_CR162","doi-asserted-by":"publisher","DOI":"10.1103\/PhysRevE.100.052107","volume":"100","author":"A Dubey","year":"2019","unstructured":"Dubey, A. & Bandyopadhyay, M. DNA breathing dynamics under periodic forcing: study of several distribution functions of relevant Brownian functionals. Phys. Rev. E 100, 052107 (2019).","journal-title":"Phys. Rev. E"},{"key":"1306_CR163","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1093\/nar\/gkl346","volume":"34","author":"S Cao","year":"2006","unstructured":"Cao, S. & Chen, S. J. Predicting RNA pseudoknot folding thermodynamics. Nucleic Acids Res. 34, 2634\u20132652 (2006).","journal-title":"Nucleic Acids Res."},{"key":"1306_CR164","doi-asserted-by":"publisher","first-page":"e213","DOI":"10.1371\/journal.pbio.0030213","volume":"3","author":"DW Staple","year":"2005","unstructured":"Staple, D. W. & Butcher, S. E. Pseudoknots: RNA structures with diverse functions. PLoS Biol. 3, e213 (2005).","journal-title":"PLoS Biol."},{"key":"1306_CR165","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/bies.950110406","volume":"11","author":"JR Wyatt","year":"1989","unstructured":"Wyatt, J. R., Puglisi, J. D. & Tinoco, I. Jr. RNA folding: pseudoknots, loops and bulges. Bioessays 11, 100\u2013106 (1989).","journal-title":"Bioessays"},{"key":"1306_CR166","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1261\/rna.635307","volume":"13","author":"OM Ottink","year":"2007","unstructured":"Ottink, O. M. et al. Ligand-induced folding of the guanine-sensing riboswitch is controlled by a combined predetermined induced fit mechanism. RNA 13, 2202\u20132212 (2007).","journal-title":"RNA"},{"key":"1306_CR167","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/79575","volume":"7","author":"JR Williamson","year":"2000","unstructured":"Williamson, J. R. Induced fit in RNA-protein recognition. Nat. Struct. Biol. 7, 834\u2013837 (2000).","journal-title":"Nat. Struct. Biol."},{"key":"1306_CR168","doi-asserted-by":"publisher","first-page":"8095","DOI":"10.1021\/bi960256a","volume":"35","author":"L Ribas de Pouplana","year":"1996","unstructured":"Ribas de Pouplana, L., Auld, D. S., Kim, S. & Schimmel, P. A mechanism for reducing entropic cost of induced fit in protein\u2014RNA recognition. Biochemistry 35, 8095\u20138102 (1996).","journal-title":"Biochemistry"},{"key":"1306_CR169","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nchembio.562","volume":"7","author":"A Haller","year":"2011","unstructured":"Haller, A., Rieder, U., Aigner, M., Blanchard, S. C. & Micura, R. Conformational capture of the SAM-II riboswitch. Nat. Chem. Biol. 7, 393\u2013400 (2011).","journal-title":"Nat. Chem. Biol."},{"key":"1306_CR170","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/bip.10251","volume":"65","author":"F Pitici","year":"2002","unstructured":"Pitici, F., Beveridge, D. L. & Baranger, A. M. Molecular dynamics simulation studies of induced fit and conformational capture in U1A-RNA binding: do molecular substates code for specificity?. Biopolymers 65, 424\u2013435 (2002).","journal-title":"Biopolymers"},{"key":"1306_CR171","doi-asserted-by":"publisher","first-page":"7947","DOI":"10.1021\/bi010680y","volume":"40","author":"N Leulliot","year":"2001","unstructured":"Leulliot, N. & Varani, G. Current topics in RNA-protein recognition: control of specificity and biological function through induced fit and conformational capture. Biochemistry 40, 7947\u20137956 (2001).","journal-title":"Biochemistry"},{"key":"1306_CR172","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1017\/S0033583506004446","volume":"39","author":"I Tinoco Jr.","year":"2006","unstructured":"Tinoco, I. Jr., Li, P. T. & Bustamante, C. Determination of thermodynamics and kinetics of RNA reactions by force. Q. Rev. Biophys. 39, 325\u2013360 (2006).","journal-title":"Q. Rev. Biophys."},{"key":"1306_CR173","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1140\/epje\/e2004-00033-4","volume":"12","author":"S Harlepp","year":"2003","unstructured":"Harlepp, S. et al. Probing complex RNA structures by mechanical force. Eur. Phys. J. E Soft Matter 12, 605\u2013615 (2003).","journal-title":"Eur. Phys. J. E Soft Matter"},{"key":"1306_CR174","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrg3841","volume":"16","author":"PG Higgs","year":"2015","unstructured":"Higgs, P. G. & Lehman, N. The RNA world: molecular cooperation at the origins of life. Nat. Rev. Genet. 16, 7\u201317 (2015).","journal-title":"Nat. Rev. Genet."},{"key":"1306_CR175","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1261\/rna.038687.113","volume":"19","author":"S Altman","year":"2013","unstructured":"Altman, S. The RNA-protein world. RNA 19, 589\u2013590 (2013).","journal-title":"RNA"},{"key":"1306_CR176","doi-asserted-by":"publisher","first-page":"a006742","DOI":"10.1101\/cshperspect.a006742","volume":"4","author":"TR Cech","year":"2012","unstructured":"Cech, T. R. The RNA worlds in context. Cold Spring Harb. Perspect. Biol. 4, a006742 (2012).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1306_CR177","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jconrel.2018.02.008","volume":"275","author":"P Rychahou","year":"2018","unstructured":"Rychahou, P. et al. Colorectal cancer lung metastasis treatment with polymer-drug nanoparticles. J. Control. Release 275, 85\u201391 (2018).","journal-title":"J. Control. Release"},{"key":"1306_CR178","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/mt.2010.243","volume":"19","author":"P Tarapore","year":"2011","unstructured":"Tarapore, P., Shu, Y., Guo, P. & Ho, S. M. Application of Phi29 motor pRNA for targeted therapeutic delivery of siRNA silencing metallothionein-IIA and survivin in ovarian cancers. Mol. Ther. 19, 386\u2013394 (2011).","journal-title":"Mol. Ther."},{"key":"1306_CR179","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.nano.2016.11.015","volume":"13","author":"F Pi","year":"2017","unstructured":"Pi, F. et al. RNA nanoparticles harboring annexin A2 aptamer can target ovarian cancer for tumor-specific doxorubicin delivery. Nanomedicine 13, 1183\u20131193 (2017).","journal-title":"Nanomedicine"},{"key":"1306_CR180","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1582","volume":"12","author":"S Guo","year":"2020","unstructured":"Guo, S. et al. Tuning the size, shape and structure of RNA nanoparticles for favorable cancer targeting and immunostimulation. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 12, e1582 (2020).","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"1306_CR181","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1080\/17435889.2025.2501919","volume":"20","author":"LP Rebolledo","year":"2025","unstructured":"Rebolledo, L. P. et al. Nucleic acid nanobiosystems for cancer theranostics: an overview of emerging trends and challenges. Nanomedicine 20, 1281\u20131298 (2025).","journal-title":"Nanomedicine"},{"key":"1306_CR182","doi-asserted-by":"publisher","first-page":"28807","DOI":"10.1039\/D4RA03823A","volume":"14","author":"T Yip","year":"2024","unstructured":"Yip, T., Qi, X., Yan, H. & Chang, Y. Therapeutic applications of RNA nanostructures. RSC Adv. 14, 28807\u201328821 (2024).","journal-title":"RSC Adv."},{"key":"1306_CR183","doi-asserted-by":"publisher","first-page":"16514","DOI":"10.1039\/D0NR02614J","volume":"12","author":"X Li","year":"2020","unstructured":"Li, X., Vieweger, M. & Guo, P. Self-assembly of four generations of RNA dendrimers for drug shielding with controllable layer-by-layer release. Nanoscale 12, 16514\u201316525 (2020).","journal-title":"Nanoscale"},{"key":"1306_CR184","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/BF00509211","volume":"83","author":"MJ Hardonk","year":"1985","unstructured":"Hardonk, M. J., Harms, G. & Koudstaal, J. Zonal heterogeneity of rat hepatocytes in the in vivo uptake of 17 nm colloidal gold granules. Histochemistry 83, 473\u2013477 (1985).","journal-title":"Histochemistry"},{"key":"1306_CR185","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/ijms26010110","volume":"26","author":"WA Haseltine","year":"2024","unstructured":"Haseltine, W. A., Hazel, K. & Patarca, R. RNA structure: past, future, and gene therapy applications. Int. J. Mol. Sci. 26, 110 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1306_CR186","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ymeth.2016.03.010","volume":"103","author":"M Biesiada","year":"2016","unstructured":"Biesiada, M., Pachulska-Wieczorek, K., Adamiak, R. W. & Purzycka, K. J. RNAComposer and RNA 3D structure prediction for nanotechnology. Methods 103, 120\u2013127 (2016).","journal-title":"Methods"},{"key":"1306_CR187","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/bs.mie.2014.10.051","volume":"553","author":"CY Cheng","year":"2015","unstructured":"Cheng, C. Y., Chou, F. C. & Das, R. Modeling complex RNA tertiary folds with Rosetta. Methods Enzymol. 553, 35\u201364 (2015).","journal-title":"Methods Enzymol."},{"key":"1306_CR188","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42528-4","volume":"14","author":"W Wang","year":"2023","unstructured":"Wang, W. et al. trRosettaRNA: automated prediction of RNA 3D structure with transformer network. Nat. Commun. 14, 7266 (2023).","journal-title":"Nat. Commun."},{"key":"1306_CR189","first-page":"1","volume":"1","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y. & Chen, S. J. Harnessing computational approaches for RNA-targeted drug discovery. RNA Nanomed. 1, 1\u201315 (2024).","journal-title":"RNA Nanomed."},{"key":"1306_CR190","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1021\/nn1024658","volume":"5","author":"J Liu","year":"2011","unstructured":"Liu, J. et al. Fabrication of stable and RNase-resistant RNA nanoparticles active in gearing the nanomotors for viral DNA packaging. ACS Nano 5, 237\u2013246 (2011).","journal-title":"ACS Nano"},{"key":"1306_CR191","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1093\/nar\/gkq1270","volume":"39","author":"PS Pallan","year":"2011","unstructured":"Pallan, P. S. et al. Unexpected origins of the enhanced pairing affinity of 2\u2032-fluoro-modified RNA. Nucleic Acids Res. 39, 3482\u20133495 (2011).","journal-title":"Nucleic Acids Res."},{"key":"1306_CR192","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ymeth.2016.03.004","volume":"103","author":"X Xu","year":"2016","unstructured":"Xu, X., Dickey, D. D., Chen, S. J. & Giangrande, P. H. Structural computational modeling of RNA aptamers. Methods 103, 175\u2013179 (2016).","journal-title":"Methods"},{"key":"1306_CR193","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1093\/nar\/gkv1479","volume":"44","author":"MJ Boniecki","year":"2016","unstructured":"Boniecki, M. J. et al. SimRNA: a coarse-grained method for RNA folding simulations and 3D structure prediction. Nucleic Acids Res. 44, e63 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1306_CR194","doi-asserted-by":"publisher","first-page":"W315","DOI":"10.1093\/nar\/gkw279","volume":"44","author":"M Magnus","year":"2016","unstructured":"Magnus, M., Boniecki, M. J., Dawson, W. & Bujnicki, J. M. SimRNAweb: a web server for RNA 3D structure modeling with optional restraints. Nucleic Acids Res. 44, W315\u2013W319 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1306_CR195","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1021\/acs.jctc.7b01228","volume":"14","author":"D Zhang","year":"2018","unstructured":"Zhang, D. & Chen, S. J. IsRNA: an iterative simulated reference state approach to modeling correlated interactions in RNA folding. J. Chem. Theory Comput. 14, 2230\u20132239 (2018).","journal-title":"J. Chem. Theory Comput."},{"key":"1306_CR196","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1261\/rna.031054.111","volume":"18","author":"JA Cruz","year":"2012","unstructured":"Cruz, J. A. et al. RNA-Puzzles: a CASP-like evaluation of RNA three-dimensional structure prediction. RNA 18, 610\u2013625 (2012).","journal-title":"RNA"},{"key":"1306_CR197","doi-asserted-by":"publisher","first-page":"7173","DOI":"10.1021\/acs.jctc.0c00798","volume":"16","author":"LZ Sun","year":"2020","unstructured":"Sun, L. Z., Jiang, Y., Zhou, Y. & Chen, S. J. RLDOCK: a new method for predicting RNA-ligand interactions. J. Chem. Theory Comput. 16, 7173\u20137183 (2020).","journal-title":"J. Chem. Theory Comput."},{"key":"1306_CR198","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1261\/rna.079020.121","volume":"28","author":"S Zhang","year":"2022","unstructured":"Zhang, S., Cheng, Y., Guo, P. & Chen, S. J. VfoldMCPX: predicting multistrand RNA complexes. RNA 28, 596\u2013608 (2022).","journal-title":"RNA"},{"key":"1306_CR199","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/modpathol.2013.251","volume":"27","author":"HS Park","year":"2014","unstructured":"Park, H. S. et al. High EGFR gene copy number predicts poor outcome in triple-negative breast cancer. Mod. Pathol. 27, 1212\u20131222 (2014).","journal-title":"Mod. Pathol."},{"key":"1306_CR200","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1713137","volume":"378","author":"JC Soria","year":"2018","unstructured":"Soria, J. C. et al. Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer. N. Engl. J. Med. 378, 113\u2013125 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1306_CR201","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/nat.2011.0313","volume":"21","author":"WM Rockey","year":"2011","unstructured":"Rockey, W. M. et al. Rational truncation of an RNA aptamer to prostate-specific membrane antigen using computational structural modeling. Nucleic Acid Ther. 21, 299\u2013314 (2011).","journal-title":"Nucleic Acid Ther."},{"key":"1306_CR202","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cpet.2021.03.004","volume":"16","author":"R Seifert","year":"2021","unstructured":"Seifert, R., Alberts, I. L., Afshar-Oromieh, A. & Rahbar, K. Prostate cancer theranostics: PSMA targeted therapy. PET Clin. 16, 391\u2013396 (2021).","journal-title":"PET Clin."},{"key":"1306_CR203","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41391-021-00394-5","volume":"25","author":"F Wang","year":"2022","unstructured":"Wang, F., Li, Z., Feng, X., Yang, D. & Lin, M. Advances in PSMA-targeted therapy for prostate cancer. Prostate Cancer Prostatic Dis. 25, 11\u201326 (2022).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"1306_CR204","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrd.2016.199","volume":"16","author":"J Zhou","year":"2017","unstructured":"Zhou, J. & Rossi, J. Aptamers as targeted therapeutics: current potential and challenges. Nat. Rev. Drug Discov. 16, 181\u2013202 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1306_CR205","doi-asserted-by":"publisher","DOI":"10.34133\/bmef.0050","volume":"5","author":"L Yu","year":"2024","unstructured":"Yu, L., Chen, L., Satyabola, D., Prasad, A. & Yan, H. NucleoCraft: the art of stimuli-responsive precision in DNA and RNA bioengineering. BME Front. 5, 0050 (2024).","journal-title":"BME Front."},{"key":"1306_CR206","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.3390\/cancers13143396","volume":"13","author":"F Sabir","year":"2021","unstructured":"Sabir, F. et al. DNA based and stimuli-responsive smart nanocarrier for diagnosis and treatment of cancer: applications and challenges. Cancers 13, 3396 (2021).","journal-title":"Cancers"},{"key":"1306_CR207","doi-asserted-by":"publisher","first-page":"91","DOI":"10.59566\/ISRNN.2024.0101091","volume":"1","author":"P Rychahou","year":"2024","unstructured":"Rychahou, P. et al. pH-responsive bond as a linker for the release of chemical drugs from RNA-drug complexes in endosome or lysosome. RNA Nanomed. 1, 91\u2013108 (2024).","journal-title":"RNA Nanomed."},{"key":"1306_CR208","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202401020","volume":"13","author":"S Zhu","year":"2024","unstructured":"Zhu, S. et al. Stimuli-responsive aptamer-drug conjugates for targeted drug delivery and controlled drug release. Adv. Healthc. Mater. 13, e2401020 (2024).","journal-title":"Adv. Healthc. Mater."},{"key":"1306_CR209","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.610533","volume":"7","author":"RG Thomas","year":"2020","unstructured":"Thomas, R. G., Surendran, S. P. & Jeong, Y. Y. Tumor microenvironment-stimuli responsive nanoparticles for anticancer therapy. Front. Mol. Biosci. 7, 610533 (2020).","journal-title":"Front. Mol. Biosci."},{"key":"1306_CR210","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1039\/D2SC01003H","volume":"13","author":"X Dong","year":"2022","unstructured":"Dong, X., Brahma, R. K., Fang, C. & Yao, S. Q. Stimulus-responsive self-assembled prodrugs in cancer therapy. Chem. Sci. 13, 4239\u20134269 (2022).","journal-title":"Chem. Sci."},{"key":"1306_CR211","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrd2468","volume":"7","author":"J Rautio","year":"2008","unstructured":"Rautio, J. et al. Prodrugs: design and clinical applications. Nat. Rev. Drug Discov. 7, 255\u2013270 (2008).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1306_CR212","doi-asserted-by":"publisher","first-page":"R877","DOI":"10.1016\/j.cub.2011.09.040","volume":"21","author":"RA Festa","year":"2011","unstructured":"Festa, R. A. & Thiele, D. J. Copper: an essential metal in biology. Curr. Biol. 21, R877\u2013R883 (2011).","journal-title":"Curr. Biol."},{"key":"1306_CR213","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1385\/BTER:103:3:229","volume":"103","author":"MP Cervantes-Cervantes","year":"2005","unstructured":"Cervantes-Cervantes, M. P., Calderon-Salinas, J. V., Albores, A. & Munoz-Sanchez, J. L. Copper increases the damage to DNA and proteins caused by reactive oxygen species. Biol. Trace Elem. Res. 103, 229\u2013248 (2005).","journal-title":"Biol. Trace Elem. Res."},{"key":"1306_CR214","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1021\/bi4017022","volume":"53","author":"DW Binzel","year":"2014","unstructured":"Binzel, D. W., Khisamutdinov, E. F. & Guo, P. Entropy-driven one-step formation of Phi29 pRNA 3WJ from three RNA fragments. Biochemistry 53, 2221\u20132231 (2014).","journal-title":"Biochemistry"},{"key":"1306_CR215","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1080\/17435889.2025.2488727","volume":"20","author":"DW Binzel","year":"2025","unstructured":"Binzel, D. W. & Guo, P. Synergistic RNA particles for spontaneous and specific cancer targeting but low toxicity due to motility and deformation. Nanomedicine 20, 1513\u20131515 (2025).","journal-title":"Nanomedicine"}],"container-title":["Nature Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41596-025-01306-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41596-025-01306-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41596-025-01306-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:02:00Z","timestamp":1785938520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41596-025-01306-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":215,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1306"],"URL":"https:\/\/doi.org\/10.1038\/s41596-025-01306-w","relation":{},"ISSN":["1754-2189","1750-2799"],"issn-type":[{"value":"1754-2189","type":"print"},{"value":"1750-2799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.G. is the licenser of Oxford Nanopore Technologies; co-founder of ExonanoRNA, LLC; and a consultant for RNA Nanobiotics.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}